Phase 2 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been fully informed about the trial and have signed a consent form agreeing to take part voluntarily.
- People aged between 18 and 70 years old (inclusive).
- People whose multiple myeloma can be measured through at least one of the following: a certain level of abnormal protein (M-protein) detected in the blood or urine, or abnormal levels of specific proteins called free light chains detected in the blood (confirm with trial site for exact values).
- People whose myeloma cells have been confirmed to carry a specific marker called BCMA, as shown by laboratory testing of bone marrow samples.
- People assessed by the treating doctor as being suitable candidates for a stem cell transplant.
Who may not be able to join:
- People diagnosed with primary plasma cell leukemia (a specific and aggressive form of blood cancer).
- People who also have a condition called amyloidosis (a disease where abnormal proteins build up in organs and tissues).
- People whose myeloma has spread to the central nervous system (the brain and spinal cord).
- People who have previously received any treatment that targeted the BCMA protein, or who have previously had CAR-T cell therapy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-022-23909171
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Persistent MRD-negative rate; Progression free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.